SEC Form 4 · accession 0001038133-15-000182
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J McGinley
Officer — Presi, Biologic. & Pharm.
Period of report
Dec 29, 2015
Accepted (ET)
Dec 31, 2015 · 1:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $39.76 | Dec 29, 2015 | A | 3,504 | A | Dec 29, 2015 | Dec 28, 2025 | Common Stock | 3,504 | 3,504 | D |
| Non-Qualified Stock Option (right to buy)F1 | $39.76 | Dec 29, 2015 | A | 10,496 | A | Dec 29, 2015 | Dec 28, 2025 | Common Stock | 10,496 | 10,496 | D |
Explanation of responses
- F1This option vests and becomes exercisable in monthly equal installments over four (4) years through December 29, 2019, subject to stockholder approval of an increase of authorized shares of Public Common Stock to at least 8,500,000 shares on or before December 31, 2022.